CEO Of COVID-Vax Making Moderna Last Year Received $4M In Stock Options, 50% Raise

MODERNA CEO in '22 Got $4M In Stock Options, 50% Raise

  • Financial records made public show the CEO of biotech company Moderna last year earned roughly $393 million from stock options he exercised and got a 50% raise.
  • The National Institutes of Health gave $1.7 billion in taxpayer funding to Moderna to develop the COVID vaccine, putting the CEO’s salary and stock options under scrutiny.
  • After the Securities an Exchange Commission report was published, Bancel said he and his wife generated $393 million from the sale of stock options and they donated $176 million in after-tax proceeds to charity in 2022.
Click to read full article

Sign Up for Our Newsletter

Join our list!

Sign up here to get our daily newsletter with the top trending headlines.